The federal government has embarked on a pilot program integrating Artificial Intelligence (AI) into the intricate process of insurance-coverage decisions, specifically targeting prior authorization. This initiative, championed by the Trump administration, aims to leverage AI’s analytical capabilities to theoretically expedite claims and curb unnecessary medical spending. However, the move has ignited a contentious debate among healthcare providers, patient advocates, and lawmakers, who express significant concerns that AI could exacerbate existing issues of care delays and wrongful denials, rather than alleviate them. The core tension lies between the promise of efficiency and the potential for automated systems to impede access to medically necessary treatments, further complicating an already burdensome healthcare landscape.
The Enduring Challenge of Prior Authorization
For many Americans, the phrase "prior authorization" evokes frustration and anxiety. It represents a bureaucratic hurdle in accessing physician-recommended medical care, from prescription medications to complex surgical procedures. Personal accounts widely published by outlets such as KFF Health News and CBS News detail the arduous journeys of patients navigating labyrinthine processes to secure insurer approval. These narratives often highlight the emotional and physical toll exacted by delays and denials, painting a picture of a system that frequently prioritizes cost control over timely patient care.
At its theoretical best, prior authorization serves as a crucial check on healthcare spending, aiming to prevent overuse of services and guide patients toward more cost-effective, yet equally efficacious, alternatives. It requires healthcare providers to obtain approval from an insurance company before a service, medication, or procedure is rendered. This mechanism is intended to ensure medical necessity and adherence to coverage policies. However, in practice, the system has become synonymous with administrative burden and significant patient hardship.
A substantial majority of physicians, as evidenced by various surveys, consistently voice profound concerns about the current state of prior authorization. The American Medical Association (AMA) has been a vocal critic, highlighting how current prior authorization practices frequently lead to delays in care. These delays can have severe consequences, including patients abandoning recommended treatments entirely while awaiting insurer verification of eligibility and medical necessity. When care is denied, patients are often forced into a time-consuming appeals process, further prolonging their access to vital medical interventions. The cumulative effect is a system perceived by many as an impediment rather than a safeguard.
AI’s Dual Promise and Peril in Healthcare
The advent of Artificial Intelligence offers a tantalizing prospect for streamlining prior authorization. With its unparalleled capacity to process and analyze vast datasets at speeds impossible for humans, AI could theoretically identify and automatically approve unambiguously allowable claims, thereby significantly reducing administrative delays. Proponents envision a future where routine approvals are instantaneous, freeing up human staff to focus on more complex cases requiring clinical judgment. This efficiency could translate into quicker patient access to care and reduced administrative overhead for providers.
However, this optimistic outlook is tempered by considerable apprehension. The integration of AI into prior authorization is facing stiff resistance due to fears that it could lead to an increase in wrongful denials of health insurance coverage. A 2025 survey conducted by the American Medical Association (AMA) underscored these anxieties, revealing that a striking 61 percent of physicians worry that AI tools will exacerbate the denial of treatments they deem medically necessary. This concern stems from the opacity of many AI algorithms and the potential for these systems to be designed with a bias towards cost-cutting, rather than patient well-being.
Health policy analysts echo these sentiments. Camm Epstein, in an email to Undark, articulated a widely held view: "AI should be used to make appropriate care easier to approve, not necessary care easier to deny." This statement encapsulates the core ethical dilemma posed by AI’s deployment in such a sensitive area of healthcare. The AMA, in response to these concerns, has advocated for greater transparency regarding the algorithms employed by AI systems and has called for insurers to provide detailed clinical reasoning to justify any denials of coverage, reinforcing the need for human oversight and accountability.
The WISeR Model: A Government Pilot with Controversy
In response to the persistent challenges of waste and fraud within Medicare, the Trump administration launched a significant demonstration project this year: the Wasteful and Inappropriate Service Reduction Model, or WISeR. This initiative, managed by the Centers for Medicare and Medicaid Services (CMS), is designed to leverage AI to identify and reduce unnecessary procedures in original Medicare, a domain where prior authorization has historically been less prevalent compared to Medicare Advantage. The WISeR project is set to run through December 2031 across six pilot states.
The model combines advanced technologies like machine learning with human clinical review to evaluate services deemed vulnerable to overuse, fraud, and abuse. Specific targets include expensive interventions such as skin and tissue substitutes, electrical nerve stimulator implants, and knee arthroscopy for knee osteoarthritis. CMS asserts that the WISeR model will "ensure timely and appropriate Medicare payment for select items and services" by integrating AI into the prior authorization process.
However, the WISeR model has immediately drawn strong criticism. Wendell Potter, a prominent advocate for health insurance reform and a former executive at Cigna, highlighted the political pushback against the model on his Substack publication, "HEALTH CARE un-covered." Further investigation by Zena Wolf, a researcher with the Center for Health & Democracy, citing reports from the Washington Post, KFF Health News, and the Seattle Times, suggests that in its initial months, the WISeR model has already caused care delays and denials in some instances across the six pilot states. This contradicts CMS’s stated goal of ensuring timely care.
A particularly contentious aspect of the WISeR model is its financial structure. Vendors participating in the program, hired to implement the AI-driven prior authorization, receive a share of what CMS terms "averted expenditures." This incentivizes these vendors financially for rejecting care requests, raising significant ethical red flags about potential conflicts of interest. Critics argue that this payment model could inadvertently encourage denials, prioritizing cost savings over patient needs. This echoes long-standing concerns about profit-making within the healthcare system based on discouraging access to medically necessary care. Consequently, several lawmakers have introduced resolutions and amendments aimed at blocking funding for the WISeR model, citing grave threats to patient access.
The Broader Regulatory Landscape and Industry Response
The contentious rollout of AI in prior authorization occurs against a backdrop of ongoing efforts to reform the system. The Biden administration, for instance, issued a significant rule in 2024 designed to reduce delays for patients enrolled in government-run plans and streamline the prior authorization process for physicians. Effective January 1 of this year (2025), these regulations mandate that insurers make urgent prior authorization decisions within 72 hours and non-urgent decisions within seven calendar days for most public sector health plans. This represented a critical step toward improving patient access and reducing the administrative burden on providers.
Concurrently, the Trump administration, alongside insurers, pledged last year to further streamline and accelerate prior authorization processes. Private insurance companies, in particular, vowed to standardize electronic requests by 2027 and committed to reducing the volume of medical services subject to prior authorization by 2026, including common procedures like colonoscopies and cataract surgeries. These commitments reflect increasing pressure from both governmental bodies and public opinion to address the systemic flaws in prior authorization.
Despite these pledges and regulatory actions, public sentiment remains largely negative. A KFF Health Tracking Poll identified prior authorizations as one of the public’s biggest burdens when seeking healthcare. This perception is particularly acute in Medicare Advantage, the privately run alternative to original Medicare, which now enrolls roughly 55 percent of eligible seniors and disabled individuals. Insurers in Medicare Advantage issue millions of full or partial claim denials annually based on prior authorization.
Recent federal government reports, including those from 2022 and specifically in June 2026 (as referenced in the original source, implying future or projected reporting), have highlighted significant issues. These reports from the HHS Office of Inspector General (OIG) indicated that Medicare Advantage plans sometimes denied beneficiaries access to services even when they apparently met coverage rules. A 2022 OIG memorandum, for instance, pointed to more than one in 10 instances where Medicare Advantage plans denied access to services that seemingly met coverage criteria. While many denials are overturned upon appeal (Medicare Advantage plans overturned 81 percent of denials in 2024), the cumbersome appeals process itself is a barrier. The OIG reports further documented instances where plans rejected requests for skilled nursing and rehabilitation admissions, raising concerns about deliberate obstacles to medically appropriate care.
A newly released Commonwealth Fund survey in June 2026 provided further stark evidence of the system’s impact. The survey found that approximately one in five American working-age adults with private insurance reported that they or a family member were denied coverage for physician-recommended medical care in 2025. Of those who experienced a prior authorization denial, a staggering 41 percent reported that it delayed their care, and more than a quarter indicated that their health problem worsened as a direct result.
Patient Impact and Expert Perspectives
The human cost of a flawed prior authorization system is profound. NBC News has reported on patients "stuck in prior authorization purgatory," running out of time or treatment options while awaiting insurer approval. These delays can transform manageable conditions into severe crises, leading to increased suffering, higher costs in the long run, and a profound erosion of trust in the healthcare system.
In response to the mounting pressure, the healthcare industry has begun to demonstrate some changes. An industry-based survey revealed that between June 2025 and April 2026, requests for prior authorization declined by 11 percent. However, a critical unknown remains: whether this reduction in requests has actually translated into a decreased denial rate, or if it simply reflects a shift in how providers approach the process. Furthermore, a survey conducted last year of health plans indicated universal agreement with the statement that "AI or algorithms without clinician or practitioner review are not used to deny prior authorization requests that involve medical necessity or clinical considerations." Insurers also promised greater transparency regarding the clinical reasoning behind their prior authorization decisions.
These assurances aim to alleviate concerns about the lack of human review in AI-driven decisions. However, placating critics will prove challenging. Jared Dashevsky, a physician and founder of Healthcare Huddle, offered a sobering assessment: "AI could eliminate barriers, reduce administrative waste, give us more time with patients. But that’s not what’s being built." Instead, he argues, the current trajectory points to an "arms race to deny faster and appeal faster. More automation of a broken system that shouldn’t exist in its current form."
The future of prior authorization, particularly with the integration of AI, remains highly uncertain. While the technology holds genuine potential to streamline administrative tasks and improve efficiency, its current implementation, particularly within models like WISeR, raises serious questions about patient access, ethical incentives, and the fundamental purpose of healthcare. The challenge for policymakers and healthcare stakeholders will be to harness AI’s capabilities for genuine patient benefit, ensuring transparency, accountability, and robust human oversight, rather than allowing it to become another tool in a system already burdened by complexity and conflicting priorities. The ultimate goal must be to ensure that technological advancements serve to enhance, not impede, medically necessary care.
Leave a Reply